According to Corcept Therapeutics
's latest financial reports the company's current revenue (TTM ) is C$0.89 Billion. In 2023 the company made a revenue of C$0.63 Billion an increase over the revenue in the year 2022 that were of C$0.54 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | C$0.84 B | 32.74% |
2023 | C$0.63 B | 17.33% |
2022 | C$0.54 B | 16.91% |
2021 | C$0.46 B | 3.37% |
2020 | C$0.45 B | 12.72% |
2019 | C$0.40 B | 16.96% |
2018 | C$0.34 B | 70.99% |
2017 | C$0.20 B | 83.15% |
2016 | C$0.10 B | 56.67% |
2015 | C$69.75 M | 126.39% |
2014 | C$30.81 M | 179.48% |
2013 | C$11.02 M | 235.26% |
2012 | C$3.28 M | |
2011 | N/A | |
2010 | N/A | -100% |
2009 | C$0.03 M |